FIGURE

Figure 3.

ID

ZDB-FIG-230513-38

Publication

Goh et al., 2023 - Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Figure 3.

MBC and MIC determination of the combination of clarithromycin (Clr) and rifaximin (Rfx) on M. abscessus ATCC 19977. The cfu counts were determined for the cells treated with 0.5×, 1×, 2×, 4× and 8 × MIC of clarithromycin in the presence of 1 × MIC of rifaximin, and vice versa. The MBC₉₀ (orange line) was defined as the lowest drug concentration required to induce >90% cell death compared with the starting inoculum (at 0 h timepoint) of the untreated control. The number of residual log₁₀ cfu/mL was determined through plating 10-fold serial dilution and compared with the starting inoculum. Statistical significance was determined by a two-tailed Student’s t-test with Welch’s correction; *P < 0.05; **P < 0.01. The dashed black line indicates the limit of detection. The experiments were carried out in duplicates; error bars represent the SD.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ JAC Antimicrob Resist